LONDON, May 25 (Reuters) - A final report into a clinical trial of an experimental drug at a London hospital that left six men seriously ill found the adverse reactions they suffered were not due to errors in how the drug was made or tested. Britain’s Medicines Healthcare products Regulatory Agency (MHRA) said in the report released on Thursday that an unexpected biological effect in humans was the most likely cause.
